Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)

Market Cap	10.26B +13.9%
Revenue (ttm)	9.28B +1.9%
Net Income	417.67M -14.8%
EPS	0.60 -15.5%
Shares Out	696.68M
PE Ratio	11.63
Forward PE	15.42
Dividend	0.30 (4.29%)
Ex-Dividend Date	n/a

Volume	697,000
Average Volume	1,210,340
Open	6.95
Previous Close	7.00
Day's Range	6.95 - 7.02
52-Week Range	5.11 - 9.46
Beta	-0.10
RSI	52.21
Earnings Date	Mar 30, 2026

About HKG:0719

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. It also provides ibuprofen bulk pharmaceutical products; a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 7,159
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0719

Financial Performance

In 2024, HKG:0719's revenue was 8.47 billion, an increase of 4.51% compared to the previous year's 8.10 billion. Earnings were 470.02 million, a decrease of -5.33%.

Financial numbers in CNY